Fractional Chief Financial Officer

Kaserta Inc. is an early-stage biotechnology company operating in stealth mode, applying AI to develop treatments for difficult-to-treat antimicrobial infections. The company is seeking a fractional CFO to work directly with the Founder and CEO across pre-seed financing, early R&D, and company-building activities.

This is a strategic finance role rather than an accounting position. The successful candidate will translate an ambitious biotech development plan into a disciplined financial strategy, support investor readiness, and help the company maintain capital efficiency as it progresses through each stage of growth. The engagement is part-time and remote, with scope expected to increase around financings, board meetings, and major strategic transactions.

• Partner with the Founder and CEO on fundraising strategy, including equity, SAFEs, grants, and non-dilutive funding structures
• Build and maintain financial models, budgets, cash-flow forecasts, and runway analyses
• Develop R&D and program-level budgets covering preclinical work, manufacturing, regulatory activities, and AI infrastructure
• Evaluate capital allocation across R&D, platform development, and business-development initiatives
• Establish financial controls and coordinate with external accountants, tax advisors, and legal counsel
• Support board and investor reporting and ensure the company remains diligence-ready at all times

• 10 or more years of finance experience, ideally in biotechnology, life sciences, or another R&D-intensive venture-backed sector
• Prior experience as a CFO, VP Finance, or senior strategic-finance executive
• Direct experience with early-stage venture financings and capitalisation structures
• Strong understanding of biotech development economics, including preclinical, clinical, manufacturing, and regulatory costs
• Demonstrated ability to build sophisticated financial models from the ground up
• Familiarity with strategic partnerships, licensing, grants, or non-dilutive financing mechanisms

Kaserta Inc. is an early-stage biotechnology startup currently in stealth mode. The company applies artificial intelligence to the discovery and development of antimicrobials targeting difficult-to-treat infections. It is in the pre-seed stage and building its core scientific and commercial foundations.